167 related articles for article (PubMed ID: 15557340)
1. Parkin phosphorylation and modulation of its E3 ubiquitin ligase activity.
Yamamoto A; Friedlein A; Imai Y; Takahashi R; Kahle PJ; Haass C
J Biol Chem; 2005 Feb; 280(5):3390-9. PubMed ID: 15557340
[TBL] [Abstract][Full Text] [Related]
2. Dyrk1A phosphorylates parkin at Ser-131 and negatively regulates its ubiquitin E3 ligase activity.
Im E; Chung KC
J Neurochem; 2015 Aug; 134(4):756-68. PubMed ID: 25963095
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin.
Hristova VA; Beasley SA; Rylett RJ; Shaw GS
J Biol Chem; 2009 May; 284(22):14978-86. PubMed ID: 19339245
[TBL] [Abstract][Full Text] [Related]
4. Site-specific Interaction Mapping of Phosphorylated Ubiquitin to Uncover Parkin Activation.
Yamano K; Queliconi BB; Koyano F; Saeki Y; Hirokawa T; Tanaka K; Matsuda N
J Biol Chem; 2015 Oct; 290(42):25199-211. PubMed ID: 26260794
[TBL] [Abstract][Full Text] [Related]
5. Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease.
Beasley SA; Hristova VA; Shaw GS
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3095-100. PubMed ID: 17360614
[TBL] [Abstract][Full Text] [Related]
6. Impact of altered phosphorylation on loss of function of juvenile Parkinsonism-associated genetic variants of the E3 ligase parkin.
Aguirre JD; Dunkerley KM; Lam R; Rusal M; Shaw GS
J Biol Chem; 2018 Apr; 293(17):6337-6348. PubMed ID: 29530980
[TBL] [Abstract][Full Text] [Related]
7. Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.
Imai Y; Soda M; Takahashi R
J Biol Chem; 2000 Nov; 275(46):35661-4. PubMed ID: 10973942
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of Parkin by the cyclin-dependent kinase 5 at the linker region modulates its ubiquitin-ligase activity and aggregation.
Avraham E; Rott R; Liani E; Szargel R; Engelender S
J Biol Chem; 2007 Apr; 282(17):12842-50. PubMed ID: 17327227
[TBL] [Abstract][Full Text] [Related]
9. Proteasomal inhibition reduces parkin mRNA in PC12 and SH-SY5Y cells.
Koch A; Lehmann-Horn K; Dächsel JC; Gasser T; Kahle PJ; Lücking CB
Parkinsonism Relat Disord; 2009 Mar; 15(3):220-5. PubMed ID: 18586549
[TBL] [Abstract][Full Text] [Related]
10. Parkin interacts with LIM Kinase 1 and reduces its cofilin-phosphorylation activity via ubiquitination.
Lim MK; Kawamura T; Ohsawa Y; Ohtsubo M; Asakawa S; Takayanagi A; Shimizu N
Exp Cell Res; 2007 Aug; 313(13):2858-74. PubMed ID: 17512523
[TBL] [Abstract][Full Text] [Related]
11. UbMES and UbFluor: Novel probes for ring-between-ring (RBR) E3 ubiquitin ligase PARKIN.
Park S; Foote PK; Krist DT; Rice SE; Statsyuk AV
J Biol Chem; 2017 Oct; 292(40):16539-16553. PubMed ID: 28710279
[TBL] [Abstract][Full Text] [Related]
12. Mutational Impact on "in-Between-Ring" (IBR) Domain of PARKIN on Protein Stability and Function.
Biswas S; Bagchi A
Appl Biochem Biotechnol; 2021 Jun; 193(6):1603-1616. PubMed ID: 33471285
[TBL] [Abstract][Full Text] [Related]
13. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
[TBL] [Abstract][Full Text] [Related]
14. Structure of phosphorylated UBL domain and insights into PINK1-orchestrated parkin activation.
Aguirre JD; Dunkerley KM; Mercier P; Shaw GS
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):298-303. PubMed ID: 28007983
[TBL] [Abstract][Full Text] [Related]
15. Structure of parkin reveals mechanisms for ubiquitin ligase activation.
Trempe JF; Sauvé V; Grenier K; Seirafi M; Tang MY; Ménade M; Al-Abdul-Wahid S; Krett J; Wong K; Kozlov G; Nagar B; Fon EA; Gehring K
Science; 2013 Jun; 340(6139):1451-5. PubMed ID: 23661642
[TBL] [Abstract][Full Text] [Related]
16. Parkin-phosphoubiquitin complex reveals cryptic ubiquitin-binding site required for RBR ligase activity.
Kumar A; Chaugule VK; Condos TEC; Barber KR; Johnson C; Toth R; Sundaramoorthy R; Knebel A; Shaw GS; Walden H
Nat Struct Mol Biol; 2017 May; 24(5):475-483. PubMed ID: 28414322
[TBL] [Abstract][Full Text] [Related]
17. Structure of the human Parkin ligase domain in an autoinhibited state.
Wauer T; Komander D
EMBO J; 2013 Jul; 32(15):2099-112. PubMed ID: 23727886
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylation by PINK1 releases the UBL domain and initializes the conformational opening of the E3 ubiquitin ligase Parkin.
Caulfield TR; Fiesel FC; Moussaud-Lamodière EL; Dourado DF; Flores SC; Springer W
PLoS Comput Biol; 2014 Nov; 10(11):e1003935. PubMed ID: 25375667
[TBL] [Abstract][Full Text] [Related]
19. Autoregulation of Parkin activity through its ubiquitin-like domain.
Chaugule VK; Burchell L; Barber KR; Sidhu A; Leslie SJ; Shaw GS; Walden H
EMBO J; 2011 Jun; 30(14):2853-67. PubMed ID: 21694720
[TBL] [Abstract][Full Text] [Related]
20. Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluor.
Foote PK; Statsyuk AV
Curr Protoc Chem Biol; 2018 Sep; 10(3):e45. PubMed ID: 30063295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
